Compare Devon Energy Corp (DVN) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Devon Energy Corp vs TransMedics Group Inc — how do they compare? Devon Energy Corp trades at $48.41 (market cap $53.81B), while TransMedics Group Inc trades at $78.32 (market cap $2.74B). The key difference: Devon Energy Corp is far larger — about 19.6× TransMedics Group Inc's market cap, and Devon Energy Corp pays a 2.62% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Devon Energy Corp for 136 Days and TransMedics Group Inc for 24 Days on average.
| DVN | TMDX | |
|---|---|---|
Market Cap | $53.81B | $2.74B |
Volume | 11,556,740 | 949,331 |
Sector | Energy | Health |
52-Week High | $52.07 | $150.42 |
52-Week Low | $31.74 | $61.99 |
Typical Hold Time | 136 Days | 24 Days |
Enterprise Value | $64.55B | $3.13B |
Dividend Yield | 2.62% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $48.69, up 1.69% today, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 10.63, net income margin of 16.67%, and positive cash flow trends. Recent news highlights activist investor pressure for strategic alternatives, including a potential sale, amid ongoing M&A interest from firms like BP.
The outlook is positive, driven by valuation discounts, earnings beats, and potential asset sales, but risks include oil price volatility and execution challenges. Analyst consensus is strongly bullish with a $62.53 price target, suggesting significant upside from current levels.
TransMedics Group (TMDX) trades at $78.17, down 3.58% on the day, with a bearish technical signal and mixed earnings history. The company reported strong 2025 results with $605.49M revenue and $190.29M net income, but 2026 projections show margin compression. Recent news highlights insider buying and leadership changes alongside legal investigations into fiduciary duties, creating a complex sentiment backdrop.
The stock offers growth potential with a consensus price target of $99.75, but faces risks from earnings misses, margin pressure, and ongoing legal scrutiny. Analyst consensus remains bullish with 69% buy ratings, yet investors must weigh robust profitability metrics against execution and regulatory uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
